title: GFR decline as an end point for clinical trials in CKD: a view from Europe.
authors.forename: Peter G M
authors.initials: PG
authors.lastname: Mol
authors.forename: Romaldas
authors.initials: R
authors.lastname: Maciulaitis
authors.forename: Thorsten
authors.initials: T
authors.lastname: Vetter
mesh_terms: D023381:Endpoint Determination / Q000379:methods / Q000592:standards*; D005060:Europe / Q000453:epidemiology; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology